Greedy Insider
FENC Insider Trades and Greediness Scores
FENNEC PHARMACEUTICALS INC. (FENC) insider trades: since Nov 18, 2025, Greedy Insider recorded 14 open-market buys and 16 sales on Form 4 from 11 insiders. The strongest recent filing scored 88 (Strong).
Who bought and who sold
Across the last 30 scoreable Form 4 transactions in FENC, 14 were open-market purchases and 16 were sales. The table lists the most recent filings with each one's Greediness Score, so the structurally unusual trades are easy to spot first.
| Insider | Role | Type | Shares | Date | Score | ||
|---|---|---|---|---|---|---|---|
| Sayad Pierre Sargis | Chief Medical Officer | Buy | 3846.0 | 21268.38 | 2026-10-12 | 64 | View |
| Evans Terry L | Chief Commercial Officer | Buy | 2326.0 | 12862.78 | 2026-10-12 | 63 | View |
| Cioffi Christiana Marie | Chief Strategy Officer | Buy | 3946.0 | 21821.38 | 2026-10-12 | 64 | View |
| Hackman Jeffrey S. | CEO | Buy | 2224.0 | 12298.72 | 2026-10-12 | 62 | View |
| Andrade Robert | CFO | Buy | 3846.0 | 21268.38 | 2026-10-12 | 66 | View |
| Brughera Marco Maria | Director | Sell | 15545.0 | 159958.05 | 2026-09-15 | 71 | View |
| Raykov Rosty | Insider | Sell | 10000.0 | 121100.0 | 2026-09-01 | 68 | View |
| Sayad Pierre Sargis | Chief Medical Officer | Sell | 12000.0 | 146160.0 | 2026-08-31 | 68 | View |
| Andrade Robert | CFO | Sell | 75000.0 | 883500.0 | 2026-08-27 | 84 | View |
| Raykov Rosty | Insider | Sell | 10000.0 | 95800.0 | 2026-08-03 | 60 | View |
The strongest recent filing
Sayad Pierre Sargis (Chief Medical Officer) bought 120,000 shares of FENNEC PHARMACEUTICALS INC. on Mar 31, 2026, a filing that scored 88 (Strong). It scored Strong because a senior insider was trading and it was direct personal ownership. The score describes the filing, not future returns. This is not investment advice.
Cluster activity
A cluster buy is present: 5 insiders (Cioffi Christiana Marie, Hackman Jeffrey S., Sayad Pierre Sargis, Evans Terry L) traded FENC the same direction within a 7-day window. Shared conviction is a stronger structural signal than a lone trade.
How this compares with FENNEC PHARMACEUTICALS INC.'s own history
Open-market buys make up 47% of the 30 scoreable FENC transactions on record between Nov 18, 2025 and Oct 12, 2026. Comparing a filing with the company's own buy/sell mix is how you tell a routine disposal from an unusual accumulation.
Methodology and sources
Scores come from six published, user-adjustable factors (insider role, cluster activity, trade size versus the insider's own history, position impact, filing urgency, and direct versus indirect ownership). The score describes the filing, not future returns. This is not investment advice.
Key facts
- Scoreable Form 4 transactions on record: 30
- Open-market buys: 14
- Sales: 16
- Distinct insiders: 11
- Strongest recent Greediness Score: 88 (Strong)
Primary sources
Related
- Strongest filing
- FENC in the live feed
- How the Greediness Score works
- What is a cluster buy?
- Form 4 transaction codes
The score describes the filing, not future returns. This is not investment advice.